WallStreetZenWallStreetZen

NASDAQ: TLIS
Talis Biomedical Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

TLIS past revenue growth

How has TLIS's revenue growth performed historically?
Company
-55.65%
Industry
9.28%
Market
17.29%
TLIS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TLIS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TLIS's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TLIS earnings and revenue history

Current Revenue
$2.1M
Current Earnings
-$62.0M
Current Profit Margin
-2,905.7%

TLIS Return on Equity

Current Company
-69.5%
Current Industry
10.5%
Current Market
188%
TLIS's Return on Equity (-69.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TLIS announces earnings.

TLIS Return on Assets

Current Company
-54.2%
Current Industry
5.3%
TLIS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TLIS Return on Capital Employed

Current Company
-72.18%
Current Industry
8.3%
TLIS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TLIS vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TLIS$2.13M-$56.93M-$62.01M-2.24%N/A
LUNG$68.68M-$52.81M-$60.84M+27.98%N/A
AXGN$159.01M-$13.33M-$21.72M+13.63%N/A
VMD$183.01M$36.68M$10.24M+23.21%+1.55%
SGHT$81.06M-$48.41M-$55.55M+60.84%N/A
View Top Medical Device Stocks

TLIS earnings dates

Next earnings date
May 9, 2024

Talis Biomedical Earnings & Revenue FAQ

What were TLIS's earnings last quarter?

On Invalid Date, Talis Biomedical (NASDAQ: TLIS) reported Q4 2023 earnings per share (EPS) of -$7.39, up 50.27% year over year. Total Talis Biomedical earnings for the quarter were -$13.46 million. In the same quarter last year, Talis Biomedical's earnings per share (EPS) was -$14.86.

If you're new to stock investing, here's how to buy Talis Biomedical stock.

What was TLIS's earnings growth in the past year?

As of Q2 2024, Talis Biomedical's earnings has grown year over year. Talis Biomedical's earnings in the past year totalled -$62.01 million.

What is TLIS's earnings date?

Talis Biomedical's earnings date is Invalid Date. Add TLIS to your watchlist to be reminded of TLIS's next earnings announcement.

What was TLIS's revenue last quarter?

On Invalid Date, Talis Biomedical (NASDAQ: TLIS) reported Q4 2023 revenue of $195.00 thousand up 24.12% year over year. In the same quarter last year, Talis Biomedical's revenue was $257.00 thousand.

What was TLIS's revenue growth in the past year?

As of Q2 2024, Talis Biomedical's revenue has grown -55.65% year over year. This is 64.93 percentage points lower than the US Medical Devices industry revenue growth rate of 9.28%. Talis Biomedical's revenue in the past year totalled $2.13 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.